Johann C. Virchow
Rostock, MV, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 122 publications
Particle engineering, aerosol physics, and pulmonary deposition of single-inhaler triple ICS/LABA/LAMA therapies in obstructive airway diseases.
Journal: European journal of internal medicine
Published: June 17, 2026
Targeting Airway Remodeling in Severe Asthma: Is There a Window of Opportunity for Biologic Therapy Predicting Effects Using Causal Artificial Intelligence?
Journal: Allergy
Published: June 04, 2026
Reply to Zhao et al.: Clarifying structural-functional coupling by FeNO status in VESTIGE.
Journal: American journal of respiratory and critical care medicine
Published: March 12, 2026
Reply to Zhao et al.: Clarifying Structural - Functional Coupling by FeNO Status in VESTIGE.
Journal: American journal of respiratory and critical care medicine
Published: March 12, 2026
Enhanced BDNF in Asthma: Does It Overrule Depression?
Journal: The journal of allergy and clinical immunology. In practice
Published: March 06, 2026
Remission in Global Airway Diseases: EUFOREA Consensus Paper.
Journal: Allergy
Published: January 16, 2026
Moving towards asthma remission from mechanistic understanding to clinical practice.
Journal: Current opinion in allergy and clinical immunology
Published: November 25, 2025
EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care.
Journal: Frontiers in allergy
Published: November 13, 2025
Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study.
Journal: Respiratory research
Published: October 24, 2025
Clinical phenotyping improves choices of biologics in asthma.
Journal: Lancet (London, England)
Published: October 06, 2025
Clinical remission in allergy and clinical immunology practice: State of the art and World Allergy Organization (WAO) call to action.
Journal: The World Allergy Organization journal
Published: August 24, 2025
Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: A post hoc analysis.
Journal: The journal of allergy and clinical immunology. In practice
Published: July 23, 2025
Last Updated: 09/26/2026